TWD 18.45
(1.37%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 357.62 Million TWD | -9.31% |
2022 | 394.32 Million TWD | 35.16% |
2021 | 291.75 Million TWD | -2.23% |
2020 | 298.41 Million TWD | -5.05% |
2019 | 314.27 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 33.9 Million TWD | -55.74% |
2024 Q1 | 76.6 Million TWD | -11.97% |
2023 Q1 | 84.63 Million TWD | -17.43% |
2023 Q3 | 87.02 Million TWD | 2.83% |
2023 FY | 357.62 Million TWD | -9.31% |
2023 Q4 | 87.02 Million TWD | 0.0% |
2023 Q2 | 84.63 Million TWD | 0.0% |
2022 Q3 | 102.5 Million TWD | 0.0% |
2022 FY | 394.32 Million TWD | 35.16% |
2022 Q4 | 102.5 Million TWD | 0.0% |
2021 FY | 291.75 Million TWD | -2.23% |
2020 FY | 298.41 Million TWD | -5.05% |
2019 FY | 314.27 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
VBI | 32.55 Million TWD | -998.516% |
Enimmune corporation | 220.1 Million TWD | -62.48% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | -180.114% |
Level Biotechnology Inc. | 151.99 Million TWD | -135.288% |
Sagittarius Life Science Corp | 135.85 Million TWD | -163.242% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | -371.43% |
TaiMed Biologics Inc. | 225.23 Million TWD | -58.779% |
GlycoNex Incorporation | 995 Thousand TWD | -35841.91% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | -39.223% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | -84.165% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -677.051% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -198.242% |
Visgeneer Inc. | 67.48 Million TWD | -429.952% |
Mycenax Biotech Inc. | -375.19 Million TWD | 195.317% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 29.891% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -459.633% |
Neith Corporation | 66.87 Million TWD | -434.778% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 75.235% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -1118.391% |
TaiRx, Inc. | 217.13 Million TWD | -64.701% |
CHO Pharma, Inc. | 268.99 Million TWD | -32.946% |
EirGenix Inc. | 236.74 Million TWD | -51.06% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -242.711% |
Lin BioScience, Inc. | 1.09 Billion TWD | 67.395% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | -34.364% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -622.892% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -32921.422% |
Lukas Biomedical Inc. | 177.45 Million TWD | -101.534% |
RBC Bioscience Corporation | 58.35 Million TWD | -512.828% |
BiOptic Inc. | 108.69 Million TWD | -229.023% |
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -108599.696% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -397257.778% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -415.677% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -13575.793% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 44.462% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -283.155% |
NaviFUS Corp. | 11.82 Million TWD | -2923.776% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | -87.503% |
Sinew Pharma Inc. | 186.25 Million TWD | -92.009% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -383.123% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | -62.262% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -762.134% |
AP Biosciences Inc | 32.25 Million TWD | -1008.802% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 80.673% |
3D Global Biotech Inc. | 5.27 Million TWD | -6680.849% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | -12.699% |
Intech Biopharm Corporation | -163.99 Million TWD | 318.069% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 68.329% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -762.114% |
TWi Biotechnology, Inc. | 169.55 Million TWD | -110.917% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | -143.244% |
TCI GENE Inc. | 174.61 Million TWD | -104.804% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -1986688.889% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | -18.836% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | -22.912% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -326.019% |
PharmaEngine, Inc. | 441.78 Million TWD | 19.051% |
Savior Lifetec Corporation | 223.36 Million TWD | -60.104% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | -38.196% |
OBI Pharma, Inc. | 2.01 Billion TWD | 82.263% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | -157.523% |
Acepodia, Inc. | 452.56 Million TWD | 20.979% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 33.888% |